Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Nivolumab plus Cabozantinib Joins Immune Checkpoint Inhibition Combination Therapies for Treatment-Naive Metastatic Clear-Cell Renal Cell Carcinoma

AuthID
P-00T-BPV
18
Author(s)
Bedke, J
·
Capitanio, U
·
Giles, RH
·
Hora, M
·
Lam, TB
·
Ljungberg, B
·
Marconi, L
·
Klatte, T
·
Volpe, A
·
Abu Ghanem, Y
·
Dabestani, S
·
Fernandez Pello, S
·
Hofmann, F
·
Bex, A
Document Type
Article
Year published
2021
Published
in EUROPEAN UROLOGY, ISSN: 0302-2838
Volume: 79, Issue: 3, Pages: 339-342 (4)
Indexing
Publication Identifiers
Pubmed: 33357997
Scopus: 2-s2.0-85099364654
Wos: WOS:000694859600018
Source Identifiers
ISSN: 0302-2838
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.